Ospedale Infermi di Rimini

Rimini 47923

2 studies enrolling now · 4 studies all time

What they study most

AML Arising From Myelodysplastic Syndrome (MDS), Autologous Stem Cell Transplant, Community-acquired Pneumonia, Influenza, COVID-19, Leukemia, Myeloid, Acute, Multiple Myeloma, Newly Diagnosed Acute Myeloid Leukemia (AML), Untreated AML

Studies at this site

• Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation — Recruiting now
• Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia — Recruiting now
• Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Participants With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation — Running, not enrolling
• A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following Autologous Stem Cell Transplant — Completed